FDA recalls oral drops

MANILA, Philippines — Oral drop medicine Cefixime (Triocef) has been recalled from the market for failing to meet the required product specifications of the Food and Drug Administration (FDA).

The Cathay Drug Company initiated the recall of the oral drops after specific lots did not meet product specifications, based on chemical tests performed by a third-party laboratory, the FDA noted.

Distributors, hospitals, retailers and pharmacies have been advised to discontinue the distribution, sale and use of the affected product.

Cefixime is commonly used to treat a variety of bacterial infections, including acute bronchitis, chronic bronchitis exacerbations, bronchiectasis with infection, secondary infections in chronic respiratory diseases and pneumonia.

It is prescribed for urinary tract infections such as pyelonephritis, cystitis and cystourethritis.

The medicine is also indicated for treating uncomplicated gonorrhea (cervical/urethral), cholecystitis, cholangitis, scarlet fever, sinusitis, tonsillitis, pharyngitis, otitis media and typhoid fever.